Skip to main content
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. will go public soon. The estimated IPO date is April 30, 2026.
IPO Price Range
$16.00 - $18.00
Shares Offered
11,800,000
Deal Size
$200.60M

Avalyn Pharma Inc. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 Dec '25 Dec '24
Net Income
-85.2-49.74
Depreciation & Amortization
-2.31-2.55
Share-Based Compensation
3.272.47
Other Operating Activities
2.761.46
Operating Cash Flow
-81.48-48.37
Capital Expenditures
-0.34-0.1
Change in Investments
10.4-131.34
Other Investing Activities
-39.96
Investing Cash Flow
10.06-91.47
Share Issuance / Repurchase
99.790.09
Financing Cash Flow
99.790.09
Net Cash Flow
28.36-139.75
Free Cash Flow
-81.83-48.46
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).